Two different legal animals
A 503A pharmacy compounds a preparation for an identified individual patient, on the prescription of a licensed prescriber. It is licensed by its state board of pharmacy. A 503B outsourcing facility registers with the FDA and may produce batches without patient-specific prescriptions, for administration in clinics and hospitals. They are governed by different sections of the Federal Food, Drug, and Cosmetic Act and held to different manufacturing standards.
The practical consequence is the one that matters to you: a 503A preparation exists because a physician wrote your name on a prescription. There is no lawful route by which a 503A pharmacy ships you a vial because you added it to a cart.
Compounded is not the same as approved
Compounded drugs are not FDA-approved and have not been evaluated by FDA for safety or effectiveness. This is not a technicality that marketing can talk around. FDA approval means an applicant ran the trials, submitted the data and had the manufacturing inspected for one specific formulation at one specific strength. A compounded preparation has not been through that, by design — it is made for one person, which is exactly why the approval pathway does not fit it.
What you get instead is a chain of accountability: a licensed prescriber who is responsible for the decision, a state-licensed pharmacy responsible for the preparation, and records at both ends. That chain is the product. It is what a grey-market vial does not have.
What a pharmacy is allowed to compound with
A 503A pharmacy cannot compound with whatever substance it likes. The eligible bulk substances are constrained, and the FDA maintains lists that change: substances it has evaluated and permits, and substances it has considered and declined, which pharmacies are not to use. Several peptides that are heavily marketed online sit in the second group or on no list at all.
This is the single most useful question to ask any provider: is the substance you are proposing eligible for compounding, and can you show me where it sits? A provider who cannot answer that is not operating the way this is supposed to work.
How to judge a compounding pharmacy
Ask whether it is licensed in your state, not just in its own. Ask whether it holds accreditation from a recognised body and whether it does sterility and potency testing on the preparations it ships, by an independent lab. Ask how it handles cold chain. These are ordinary questions with ordinary answers at a good pharmacy.
Key points
- 503A compounds for one named patient on a prescription; 503B produces batches for clinical administration.
- Compounded is not FDA-approved, and no amount of marketing changes that sentence.
- Not every substance is eligible. Ask where yours sits before you pay for it.
AZZA Medical is not a medical provider and does not practice medicine. Medical services are provided exclusively by independently licensed physicians of our partner physician network and their affiliated professional entities.
Compounded drugs are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
This is not emergency care. AZZA Medical does not provide urgent or emergency medical services. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room.